George Vasmatzis, Ph.D., and John Cheville, M.D., co-directors of the Biomarker Program at the Center for Individualized Medicine at Mayo Clinic, introduce us to the world and work of Biomarkers.

The Biomarker Discovery Program is a multidisciplinary team that includes oncologists, surgeons, pathologists, molecular biologists, bioengineers, bioinformaticians and others. By combining expertise, the program takes a clinical question, and answers it through a four-phase approach: Discovery, experimental validation, preclinical validation and clinical validation.

The Co-Directors answer the following three questions in this video:

1. How do you identify a Biomarker?
2. What projects are you currently working on?
3. What are some challenges you face?

Discover the latest in Biomarkers, and Genomics, at our annual Individualizing Medicine Conferencethis year, October 6-8!

Tags: biomarker, Biomarker Discovery Program, biomarkers, Bladder Cancer, breast cancer, center for individualized medicine, dna test, DNA Testing, gene sequencing, genome science, genomic medicine, genomics, HER2, individualized medicine, John Cheville, Modern Pathology, personal genomics, personalized medicine, predictive medicine, Uncategorized